•  
  •  
  •  
  •  

2025-12-01 10:35:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Venus Remedies Ltd update on resolution Of Income Tax matters and Elimination of Contingent Liability
  • MIC Electronics Ltd receives LoA worth Rs. 1.49 crore
  • Royal Orchid Hotels Ltd Launches Regenta Anantam Resort, Khatu Shyam Ji
  • ABD Maestro unveils YELLO Designer Whisky, a bold new fusion of Scotch and Indian Malts
  • Escorts Kubota Ltd Tractor Volume grew by 17.9% in November 2025

Keywords Selected:  Cipla

Research

  • ICICI Direct on Cipla: Consolidation breakout signifies resumption of primary up trend...

Stock Report

  • Cipla Launches India's First Dedicated Lung Health Diagnostics Center in Delhi
  • Cipla Ltd consolidated Q2FY26 net profit increases to Rs. 1351.17 crores
  • Lilly and Cipla sign a distribution and promotion agreement for Yurpeak® in India
  • SES ESG Research Pvt Ltd assigns ESG rating of 69.3 to Cipla Ltd
  • Cipla Ltd Q1 FY2025-26 consolidated profit up at Rs. 1297.62 crores
  • Cipla Health takes a humorous spin on real life stories with Astaberry's campaign 'Get the Rich Look'
  • Cipla Health launches a new campaign for Cipladine with Neena Gupta as brand ambassador
  • Cipla Health launches a new campaign for Cipladine with Neena Gupta as brand ambassado
  • Update on USFDA inspection at manufacturing facility of Medispray in Kundaim, Goa, India
  • Cipla Limited receives USFDA final approval for ANDA Protein-bound Paclitaxel
  • USFDA inspection at manufacturing facility of Medispray in Kundaim, Goa, India
  • Cipla Ltd's Q1FY25 consolidated net profit climbs to Rs. 1177.64 crores
  • Cipla Limited's Kurkumbh facility gets VAI classification from USFDA
  • Orchid Pharma partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India
  • USFDA inspection at Cipla Ltd's manufacturing facility in Patalganga, Maharashtra, India
  • Cipla Ltd gets 6 observations from USFDA for Goa facility
  • Cipla EU to invest an additional EUR 3 million in Ethris
  • Cipla Ltd recommends final dividend of Rs. 13
  • Cipla Ltd posts consolidated PAT of Rs. 939.04 crores in Q4 FY24
  • Cipla Ltd receives 1 observation from USFDA for Kurkumbh facility
  • Cipla Health Ltd completes purchase of a business undertaking from Ivia Beaute Pvt Ltd
  • Cipla Health strengthens its play in beauty and personal care
  • Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in India
  • USFDA completes PAI of Cipla's Qidong unit

Latest Post

  • Venus Remedies Ltd update on resolution Of Income Tax matters and Elimination of Contingent Liability
  • MIC Electronics Ltd receives LoA worth Rs. 1.49 crore
  • Royal Orchid Hotels Ltd Launches Regenta Anantam Resort, Khatu Shyam Ji
  • ABD Maestro unveils YELLO Designer Whisky, a bold new fusion of Scotch and Indian Malts
  • Escorts Kubota Ltd Tractor Volume grew by 17.9% in November 2025


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024